Abstract
Quality of life (QOL) and patient-reported outcomes (PROs) assessments in immunodeficiency patients, including those with chronic severe neutropenia conditions, are imperative to determining modifiable health-related features to optimize care. We present the largest study to date of QOL in those with chronic severe neutropenia conditions with further evaluation of patient provider satisfaction and patient-reported outcome measures. Subjects completed electronic surveys assessing QOL, PROs, and patient provider satisfaction. There is a significantly negative impact of a chronic severe neutropenia disorder on QOL, fatigue, physical function, cognitive function and pain in adult patients when compared to controls. Children with a chronic neutropenia condition had comparable QOL to controls, but reported fewer depressive symptoms, improved mobility, and stronger self-reported peer relationships. Adults had worse scores for QOL, depression and fatigue when compared to children. Adult and pediatric chronic severe neutropenia patients or their caregivers felt that their medical provider was compassionate, trustworthy, and accessible. However, less than 50% of adult patients agreed their clinician had excellent expertise in white blood cell disorders. Chronic neutropenia complexly affect QOL and PROs. An analysis of these parameters allows for targeted interventions to improve patient psychosocial, physical and neurocognitive health.
Similar content being viewed by others
Abbreviations
- G-CSF:
-
Granulocyte colony-stimulating factor
- GM-CSF:
-
Granulocyte–macrophage colony-stimulating factor
- HRQoL:
-
Health-related quality of life
- IQR:
-
Interquartile range
- MID:
-
Minimally important difference
- PROMIS:
-
Patient-reported outcomes measurement information system
- PROs:
-
Patient-reported outcomes
- QOL:
-
Quality of life
References
Quinti I, Pulvirenti F. Health-related quality of life and patients’ empowerment in the health care of primary immune deficiencies. J Clin Immunol. 2017;37:615–6.
Similuk MN, Wang A, Lenardo MJ, Erby LH. Life with a primary immune deficiency: a systematic synthesis of the literature and proposed research agenda. J Clin Immunol. 2016;36:123–33.
Peshko D, Kulbachinskaya E, Korsunskiy I, Kondrikova E, Pulvirenti F, Quinti I, et al. Health-related quality of life in children and adults with primary immunodeficiencies: a systematic review and meta-analysis. J Allergy Clin Immunol Pract. 2019;7(1929–1957):e5.
Jones EA, Bolyard AA, Dale DC. Quality of life of patients with severe chronic neutropenia receiving long-term treatment with granulocyte colony-stimulating factor. JAMA. 1993;270:1132–3.
Fazio MT, Glaspy JA. The impact of granulocyte colony-stimulating factor on quality of life in patients with severe chronic neutropenia. Oncol Nurs Forum. 1991;18:1411–4.
Cleary PD, Morrissey G, Yver A, Oster G. The effects of rG-CSF on health-related quality of life in children with congenital agranulocytosis. Qual Life Res. 1994;3:307–15.
PROMIS [Internet]. Available from: http://www.healthmeasures.net/explore-measurement-systems/promis. 13 Jul 2019.
Varni JW, Burwinkle TM, Seid M, Skarr D. The PedsQL 4.0 as a pediatric population health measure: feasibility, reliability, and validity. Ambul Pediatr. 2003;3:329–41.
PedsQL TM (Pediatric Quality of Life Inventory TM) [Internet]. Available from: https://www.pedsql.org/index.html. 13 Jul 2019.
Varni JW, Limbers CA. The PedsQL 4.0 generic core scales young adult version: feasibility, reliability and validity in a university student population. J Health Psychol. 2009;14:611–22.
Varni JW, Seid M, Kurtin PS. PedsQL 4.0: reliability and validity of the Pediatric Quality of Life Inventory version 4.0 generic core scales in healthy and patient populations. Med Care. 2001;39:800–12.
Helgeson VS, Holmbeck GN. An introduction to the special issue on peer relations in youth with chronic illness. J Pediatr Psychol. 2015;40:267–71.
Dale DC, Crawford J, Klippel Z, Reiner M, Osslund T, Fan E, et al. A systematic literature review of the efficacy, effectiveness, and safety of filgrastim. Support Care Cancer. 2018;26:7–20.
Moore DC, Pellegrino AE. Pegfilgrastim-induced bone pain: a review on incidence, risk factors, and evidence-based management. Ann Pharmacother. 2017;51:797–803.
Fioredda F, Lanza T, Gallicola F, Riccardi F, Lanciotti M, Mastrodicasa E, et al. Long-term use of pegfilgrastim in children with severe congenital neutropenia: clinical and pharmacokinetic data. Blood. 2016;128:2178–81.
Fioredda F, Calvillo M, Lanciotti M, Lanza T, Giunti L, Castagnola E, et al. Pegfilgrastim in children with severe congenital neutropenia. Pediatr Blood Cancer. 2010;54:465–7.
Dale DC, Bolyard AA, Schwinzer BG, Pracht G, Bonilla MA, Boxer L, et al. The severe chronic Neutropenia International Registry: 10-year follow-up report. Support Cancer Ther. 2006;3:220–31.
Cheretakis C, Locker D, Dror Y, Glogauer M. Oral health-related quality of life of children with neutropenia. Spec Care Dent. 2007;27:6–11.
Improving Patient Satisfaction|Journal of Hospital Medicine [Internet]. Available from: https://www.journalofhospitalmedicine.com/jhospmed/article/127830/improving-patient-satisfaction. 30 Jan 2020.
About NEUPOGEN® (filgrastim)|G-CSF Injection [Internet]. Amgen, Inc. Available from: http://www.neupogenhcp.com/en/g-csf. 27 Feb 2020
Pickett K, Loveman E, Kalita N, Frampton GK, Jones J. Educational interventions to improve quality of life in people with chronic inflammatory skin diseases: systematic reviews of clinical effectiveness and cost-effectiveness. Health Technol Assess. 2015;19(1–176):v–vi.
Flanagan S, Damery S, Combes G. The effectiveness of integrated care interventions in improving patient quality of life (QoL) for patients with chronic conditions. An overview of the systematic review evidence. Health Qual Life Outcomes. 2017;15:188.
Grey M. Coping skills training for youths with diabetes. Diabetes Spectrum. 2011;24:70–5.
Compas BE, Jaser SS, Dunn MJ, Rodriguez EM. Coping with chronic illness in childhood and adolescence. Annu Rev Clin Psychol. 2012;8:455–80.
Acknowledgements
The authors acknowledge the assistance of the National Neutropenia Network, specifically Kate Bottiger, in soliciting patients for study enrollment. The mission of the National Neutropenia Network is to promote awareness, education, and research, and to provide a support system for patients with severe chronic neutropenia and their families through a national resource network.
Patient reported outcome survey questions provided by © 2010-2016 PROMIS Health Organization and PROMIS Cooperative Group. Quality of life assessed via PedsQL™—Pediatric Quality of Life Inventory™, copyright © 1998 JW Varni, Ph.D. and all rights reserved. Study tools administered electronically via the QuestionPro© survey software.
Author information
Authors and Affiliations
Contributions
Drs. TFM and KW conceptualized and designed the study. Dr. TFM constructed the manuscript as well as analyzed/interpreted study data. Dr. KW, Dr. JAC, Dr. LEM and Mr. HM assisted in editing the manuscript. Dr. LEM assisted in constructing the online surveys. Mr. HM additionally provided statistical support.
Corresponding author
Ethics declarations
Conflict of interest
The authors note no conflicts of interest.
Ethical approval
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Michniacki, T.F., Merz, L.E., McCaffery, H. et al. Quality of life and patient-reported outcomes in chronic severe neutropenia conditions. Int J Hematol 113, 735–743 (2021). https://doi.org/10.1007/s12185-021-03089-8
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12185-021-03089-8